Length of Pro Medicus's Contracts Looks Positive -- Market Talk
Dow Jones
Jun 01
0442 GMT - The length of Pro Medicus's new contracts is seen as good news at RBC Capital Markets. Analyst Jackson Lee reminds investors that TidalHealth agreed to a seven-year contract, and that Allegheny stuck to a five-year term for its renewal. He writes in a note to clients that the duration of both represents a step forward in debunking the widespread narrative over AI disruption. Lee writes that neither company has shown signs of seeking a shorter-term contract, which would have kept open the option of exploring AI native alternatives. RBC has a sector-perform rating and A$195.00 target price on the stock, which is up 8.1% at A$142.95. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 01, 2026 00:42 ET (04:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.